🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oil Down as Market Awaits OPEC+ Moves, New Data

Published 01/12/2020, 02:43 pm
Updated 01/12/2020, 02:56 pm
© Reuters.
LCO
-
CL
-
MRNA
-

By Gina Lee

Investing.com – Oil was down on Tuesday morning in Asia, with investors unclear as to whether the world’s major producers would extend output cuts, which would support oil prices.

Brent oil futures were down 0.71% at $47.54 by 11:55 PM ET (3:55 AM GMT) and WTI futures fell 0.79% to $44.98.

The Organization of the Petroleum Exporting Countries (OPEC) and its allies (OPEC+) put off output policy talks until Thursday, Reuters reported. The market is now waiting to see whether the organization will continue with current production cuts of 7.7 million barrels per day or curb those cuts. The group was originally set to ease cuts by about 2 million bpd starting in January, but demand remains weak.

Some investors were expectant that the cuts would happen.

"I suspect that, ultimately, OPEC+ will extend the production cut programme by three months," Mizuho Securities director of energy futures Bob Yawger told Reuters. 

But any accord would require some producers to agree to larger cuts moving forward, with those barrels being allocated to the United Arab Emirates (UEA) "for the balance of the agreement", Yawger added.

November was a strong month for oil, with both benchmarks rising by about 27% as investors held on to hopes that a vaccine would speed up a return to normalcy from COVID-19 lockdowns.

Investors are now weighing a renewed surge of COVID-19 cases around the world and new lockdowns in places as disparate as London, Hong Kong and New York as well as the likely approval of multiple COVID-19 vaccines in the coming weeks. Moderna Inc (NASDAQ:MRNA) will request clearance for its vaccine candidate mRNA-1273 in the U.S. and Europe, the company said on Monday.

Investors are also looking to distill testimony from U.S. Federal Reserve Chairman Jerome Powell and Treasury Secretary Steve Mnuchin on Monday to the Senate Banking Committee, both of whom said the US economy is on the path to recovery but will need some help. 

Mnuchin called on Congress to use the CARES Act, worth $455 billion, to put in place a stimulus package to give the economy a boost. Powell, in turn, pointed to moderate growth as a concern.

Powell will continue to testify before Congress later in the day and on Wednesday, with the Fed convening for its policy meeting on Dec. 15 and 16.

Also supporting prices, China’s Caixin manufacturing Purchasing Managers Index (PMI) for November came in at 54.9% in November, up from 53.6 in October.

Investors are now looking to crude oil supply data from the American Petroleum Institute, due later in the day.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.